rs2076697
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_005857.5(ZMPSTE24):āc.651T>Cā(p.Asp217=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0846 in 1,613,256 control chromosomes in the GnomAD database, including 7,390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.080 ( 652 hom., cov: 32)
Exomes š: 0.085 ( 6738 hom. )
Consequence
ZMPSTE24
NM_005857.5 synonymous
NM_005857.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.17
Genes affected
ZMPSTE24 (HGNC:12877): (zinc metallopeptidase STE24) This gene encodes a member of the peptidase M48A family. The encoded protein is a zinc metalloproteinase involved in the two step post-translational proteolytic cleavage of carboxy terminal residues of farnesylated prelamin A to form mature lamin A. Mutations in this gene have been associated with mandibuloacral dysplasia and restrictive dermopathy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 1-40271917-T-C is Benign according to our data. Variant chr1-40271917-T-C is described in ClinVar as [Benign]. Clinvar id is 95316.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40271917-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.17 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMPSTE24 | NM_005857.5 | c.651T>C | p.Asp217= | synonymous_variant | 6/10 | ENST00000372759.4 | NP_005848.2 | |
ZMPSTE24 | XM_047427582.1 | c.402T>C | p.Asp134= | synonymous_variant | 5/9 | XP_047283538.1 | ||
ZMPSTE24 | XM_047427590.1 | c.651T>C | p.Asp217= | synonymous_variant | 6/7 | XP_047283546.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMPSTE24 | ENST00000372759.4 | c.651T>C | p.Asp217= | synonymous_variant | 6/10 | 1 | NM_005857.5 | ENSP00000361845 | P1 | |
ZMPSTE24 | ENST00000675937.1 | c.651T>C | p.Asp217= | synonymous_variant, NMD_transcript_variant | 6/11 | ENSP00000502683 | ||||
ZMPSTE24 | ENST00000674703.1 | c.*492T>C | 3_prime_UTR_variant, NMD_transcript_variant | 7/11 | ENSP00000501674 | |||||
ZMPSTE24 | ENST00000675754.1 | c.*393T>C | 3_prime_UTR_variant, NMD_transcript_variant | 7/11 | ENSP00000502555 |
Frequencies
GnomAD3 genomes AF: 0.0804 AC: 12228AN: 152172Hom.: 648 Cov.: 32
GnomAD3 genomes
AF:
AC:
12228
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.108 AC: 27106AN: 251210Hom.: 1953 AF XY: 0.110 AC XY: 14998AN XY: 135814
GnomAD3 exomes
AF:
AC:
27106
AN:
251210
Hom.:
AF XY:
AC XY:
14998
AN XY:
135814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0850 AC: 124166AN: 1460966Hom.: 6738 Cov.: 32 AF XY: 0.0884 AC XY: 64244AN XY: 726792
GnomAD4 exome
AF:
AC:
124166
AN:
1460966
Hom.:
Cov.:
32
AF XY:
AC XY:
64244
AN XY:
726792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0804 AC: 12243AN: 152290Hom.: 652 Cov.: 32 AF XY: 0.0822 AC XY: 6122AN XY: 74476
GnomAD4 genome
AF:
AC:
12243
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
6122
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
752
AN:
3472
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3Other:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 18, 2019 | - - |
not provided, no classification provided | literature only | ZMPSTE24 homepage - Leiden Muscular Dystrophy pages | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 23, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Mandibuloacral dysplasia with type B lipodystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Lethal tight skin contracture syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at